APS in Lebanon.

55
APS in Lebanon. Imad Uthman, MD, MPH Imad Uthman, MD, MPH Professor of Clinical Medicine Professor of Clinical Medicine Head, Division of Rheumatology Head, Division of Rheumatology American University of Beirut Medical Center American University of Beirut Medical Center Beirut, Lebanon Beirut, Lebanon

description

APS in Lebanon. Imad Uthman , MD, MPH Professor of Clinical Medicine Head, Division of Rheumatology American University of Beirut Medical Center Beirut, Lebanon. - PowerPoint PPT Presentation

Transcript of APS in Lebanon.

Page 1: APS in Lebanon.

APS in Lebanon.

Imad Uthman, MD, MPHImad Uthman, MD, MPHProfessor of Clinical MedicineProfessor of Clinical MedicineHead, Division of RheumatologyHead, Division of RheumatologyAmerican University of Beirut Medical CenterAmerican University of Beirut Medical CenterBeirut, LebanonBeirut, Lebanon

Page 2: APS in Lebanon.

Study Of The Clinical And Serological Characteristics And Long-term Evolution of APS Patients

At The American University of Beirut Medical Center (AUBMC).

Page 3: APS in Lebanon.

The Lebanese APS Study Group.

Purpose: – To evaluate prospectively the clinical

manifestations and the long-term evolution of the APS patients seen at AUBMC and, in the future, expand this to other centers in the country.

Page 4: APS in Lebanon.

The Lebanese APS Study Group.

Methods: – All patients included have fulfilled at least

one clinical criterion and one laboratory criterion.

– A standardized questionnaire was used to collect demographic data, risk factors for thrombosis, coexisting autoimmune disorders, and specific morbidities due to APS, and data was stored into a registry.

Page 5: APS in Lebanon.

The Lebanese APS Study Group.

Results: – 200 patients logged into the registry so

far.– Cases were identified from the lab records

(positive ACA and/or LAC tests)

Page 6: APS in Lebanon.

Demographic

Lebanon Europe*

Female: 144 (72%) 820 (82%)

Male 46 (28%) 180 (18%)

Cervera R, et al on behalf of the "Euro-Phospholipid Project Group”: Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027

Page 7: APS in Lebanon.

Underlying Conditions

Lebanon Europe*

SLE 78 (39%) 362 (36.2%)

Primary APS 70 (35%) 531 (53.1%)

RA 4 (2%) 18 (1.8%)

Systemic Sclerosis 4 (2%) 7 (0.7%)

Sjogren’s Syndrome

2 (1%) 22 (2.2%)

Lupus Like Syndrome

2 (1%) 50 (5.0%)

*Cervera R, et al : Arthritis Rheum 2002; 46: 1019-1027

Page 8: APS in Lebanon.

Neurological Manifestations

Lebanon Europe

Stroke 34 (17%) 198 (19.8%)

Transient Ischemic Attack

16 (8%) 111 (11.1%)

Epilepsy 16 (8%) 70 (7.0%)

Migraine 14 (7%) 202 (20.2%)

Cerebellar ataxia: 6 (3%) 7 (0.7%)

Cerebral venous thrombosis:

4 (2%) 7 (0.7%)

Vertigo 4 (2% )

Page 9: APS in Lebanon.

Cardiac Manifestations

Lebanon Europe

Angina 6 (3%) 27 (2.7%)

Valve dysfunction 3 (1.5%) 116 (11.6%)

Coronary artery bypass graft

2 (1%) 11 (1.1%)

Chronic cardiomyopathy

2 (1%) 29 (2.9%)

Myocardial infarction 55 (5.5%)

Page 10: APS in Lebanon.

Intestinal Manifestations

Lebanon Europe

Splenic infarcts: 10 (5%) 11 (1.1%)

Pancreatic infarction:

6 (3%) 5 (0.5%)

GI ischemia: 6 (3%) 15 (1.5%)

Liver infarctions: 4 (2%)

Budd Chiari syndrome

1 (0.5%) 7 (0.7%)

Addison’s Disease: 1 (0.5%) 4 (0.4%)

Page 11: APS in Lebanon.

Pulmonary Manifestations

Lebanon Europe

Pulmonary embolism & infarction

15 (7.5%)

141 (14.1%)

ARDS 3 (1.5%)

7 (0.7%)

Page 12: APS in Lebanon.

Osteoarticular Manifestations

Lebanon Europe

Arthralgias: 28 (14%) 387 (38.7%)

Arthritis: 10 (5%) 271 (27.1%)

Avascular necrosis:

8 (4%) 24 (2.4%)

Page 13: APS in Lebanon.

Obstetric Manifestations

Lebanon Europe

Preeclampsia/ eclampsia:

4 (2%) 56 (9.5%)/

26 (4.4%)

Abruptio Placenta:

4 (2%) 12 (2.0%)

Page 14: APS in Lebanon.

Fetal Manifestations

Lebanon Europe

pregnancies 296 1580

Early Fetal Loss (<10 weeks)

56 (19%) 560 (35.4%)

Late Fetal Loss (>10 weeks):

20 (6.75%) 267 (16.9%)

Live birth 200 (67%) 753 (47.7%)

Premature birth, no. premature/no. live births

12/200 (6%) 80/753 (10.6%)

Page 15: APS in Lebanon.

Thrombotic Manifestations

Lebanon Europe

LE DVT 56 (28%) 389 (38.9%)

LE superficial phlebitis

6 (3%) 117(11.7%)

Page 16: APS in Lebanon.

Renal Manifestations

Lebanon Europe

Renal vein thrombosis

3 (1.5%)

Renal infarction 2 (1%)

Renal Manifestations

27 (2.7%)

Page 17: APS in Lebanon.

THE LEBANESE APS STUDY GROUP

Results: – In decreasing frequency, the most common

complications were: • DVT

• Obstetric problems

• Stroke

• TIA

• Seizures

• Migraines

• Splenic infarcts

Page 18: APS in Lebanon.

THE LEBANESE APS STUDY GROUP

Conclusion: – DVT and strokes are the most common

non-obstetric complications of APS in Lebanon.

– Many patients suffer from more than one complication, such as DVT or ischemic stroke.

Page 19: APS in Lebanon.

Nightmare On Bliss StreetCatastrophic Cerebral APS

Page 20: APS in Lebanon.

Case Presentation

Mrs. HM 61 year old female presented to ER on March 8, 09 with acute onset of dysarthria and left cheek numbness.

One month before she had recurrent episodes of vertigo and unsteadiness, was told she had ear problems.

Page 21: APS in Lebanon.

Background

Hypothyroid and dyslipidemic.Smoker Married 3 childrenNo Hx of abortion, fetal loss, or PreclampsiaHx of premature delivery twice (at 32,30wks)No Hx of DVT.

Page 22: APS in Lebanon.

Physical Exam

BP: 200/100.Dysarthria.Right ptosis. Cerebellar signs: Normal Gait: Normal Sensory Exam: Normal

Page 23: APS in Lebanon.

MRI Brain: 9 March 09

Impression: – Multiple acute lacunar infarcts in

watershed distribution in both centrum semi-ovale as well as in the left precentral gyrus.

– Subacute infarct in the left occipital area.

Page 24: APS in Lebanon.

MRI Brain: 9 March 09

Page 25: APS in Lebanon.

MRI Brain: 9 March 09

Page 26: APS in Lebanon.

MRI Brain: 9 March 09

Page 27: APS in Lebanon.

MRI Brain: 9 March 09

Page 28: APS in Lebanon.

Assessment

Neurology: R/O Vasculitis

Rheumatology: R/O APS

Page 29: APS in Lebanon.

Laboratory Evaluation

Lupus anticoagulant: Positive

ACA IgG: 96.4 GPLu/mL ACA IgM: <7 MPLu/mL

Anti ß2-Glycoprotein I IgG: >200 U/ml Anti ß2-Glycoprotein I IgM: <2 U/ml

Page 30: APS in Lebanon.

Laboratory Evaluation

ANA: NegativeAnti ds-DNA: NegativeC-ANCA: Negative

Page 31: APS in Lebanon.

Course in Hospital

Started on Heparin, Plavix.Next day ( March 10) marked

improvement in speech

Page 32: APS in Lebanon.

Course in Hospital

March 11:– Worsening dysarthria.– PTT was in the therapeutic range.– Started on Prednisone 1mg/kg by the

neurology team (for suspicion of CNS vasculitis).

Page 33: APS in Lebanon.

March 14 PM:– Worsening of numbness and weakness in the

right upper extremity + had tongue numbness – INR 2.6– BP: 175/110 – Solu-Medrol 250 mg IV given – Restarted on IV Heparin

Course in Hospital

Page 34: APS in Lebanon.

15 March Evening:– Acute right sided weakness 0/5 motor power

Rt side + Aphasia.

Course in Hospital

Page 35: APS in Lebanon.

MRI Brain: 15 March 09

Impression: – Acute infarcts in the left parietal and frontal

lobes and in the watershed territories bilaterally more so on the left.

– Small focus of hemorrhage in the left parietal lobe.

Page 36: APS in Lebanon.

MRI Brain: 15 March 09

Page 37: APS in Lebanon.

MRI Brain: 15 March 09

Page 38: APS in Lebanon.

MRI Brain: 15 March 09

Page 39: APS in Lebanon.

MRI Brain: 15 March 09

Page 40: APS in Lebanon.

16 March:– 12 PM: Unconscious, seizure like activity.

– Acute respiratory distress: mechanical ventilation.

– Physical Exam: Pupils mid sized dilated Absent corneal reflexAbsent Oculocephalic reflex Decerebrate posturing Bilateral positive Babinski

Course in Hospital

Page 41: APS in Lebanon.

CT Brain: 16 March 09

Impression: – Hemorrhagic transformation in the left frontal

lobe infarct with significant surrounding edema, mass effect, trans-tentorial and uncal herniations with brain stem infarct.

Page 42: APS in Lebanon.

CT Brain: 16 March 09

Page 43: APS in Lebanon.

CT Brain: 16 March 09

Page 44: APS in Lebanon.

CT Brain: 16 March 09

Page 45: APS in Lebanon.

CT Brain: 16 March 09

Page 46: APS in Lebanon.

17 March (one week after her initial presentation):– Declared brain dead, family decided to stop

mechanical ventilation.

Course in Hospital

Page 47: APS in Lebanon.

Nightmare on Bliss Street

The Autopsy

Page 48: APS in Lebanon.

Brain Gross Pathology

Soft, edematous Lt Sub-falcial

herniationUncal herniation and

necrosis.

Page 49: APS in Lebanon.

Terminal Massive ICH

Recent large intracerebral hemorrhage, left frontal and parietal lobes.

Page 50: APS in Lebanon.

Fibrin thrombi within a vessel

Free-floating small fibrin thrombi within rare arterioles and venules in cortex, leptomeninges, and white matter hemorrhage.

Page 51: APS in Lebanon.

LF WM, recent hemorrhage, fibrin

Page 52: APS in Lebanon.

Small recent infarcts, Left Occipital Cortex

Focal Perivascular lymphocytic infiltration.

Page 53: APS in Lebanon.

Microangiitis, vasa vasorum

Perivascular lymphocytic infiltrates, multifocal, involving small vessels of vasa vasorum, right and left carotid arteries, consistent with small vessel angiitis.

Page 54: APS in Lebanon.

Summary

This is the first large series of APS patients from Lebanon.

Although testing for APS is available in major hospitals in the country, the condition is still largely unrecognized by the medical community.

Further testing including genetic studies are planned in our cohort.

Page 55: APS in Lebanon.

Thank You